Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 2,322,900 | 2,045,500 | 1,899,600 | 1,678,600 | 1,447,000 |
| Cost of Goods | 625,600 | 516,600 | 491,000 | 489,800 | 408,300 |
| Gross Profit | 1,697,300 | 1,528,900 | 1,408,600 | 1,188,800 | 1,038,700 |
| Operating Expenses | 1,205,100 | 1,057,000 | 988,700 | 889,500 | 754,700 |
| Operating Income | 492,800 | 472,500 | 419,900 | 300,100 | 284,300 |
| Interest Expense | 17,200 | 9,800 | 4,400 | 3,100 | 2,400 |
| Other Income | 668,400 | 48,500 | -27,300 | -13,400 | -13,700 |
| Pre-tax Income | 1,144,000 | 511,200 | 388,200 | 283,600 | 268,200 |
| Income Tax | 332,900 | 122,100 | 96,700 | 46,900 | 50,200 |
| Net Income Continuous | 811,100 | 389,100 | 291,500 | 236,700 | 218,000 |
| Net Income | $811,100 | $389,100 | $291,500 | $236,700 | $218,000 |
| EPS Basic Total Ops | 1.27 | 0.58 | 0.42 | 0.35 | 0.32 |
| EPS Basic Continuous Ops | 1.27 | 0.58 | 0.42 | 0.34 | 0.32 |
| EPS Diluted Total Ops | 1.25 | 0.57 | 0.41 | 0.33 | 0.31 |
| EPS Diluted Continuous Ops | 1.25 | 0.57 | 0.41 | 0.33 | 0.30 |
| EBITDA(a) | $561,400 | $535,400 | $473,600 | $358,100 | $340,800 |